Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemical Inhibitors Targeting the Oncogenic m6A Modifying Proteins
Yue Huang, Wenyang Xia, Ze Dong, et al.
Accounts of Chemical Research (2023) Vol. 56, Iss. 21, pp. 3010-3022
Closed Access | Times Cited: 25

Showing 25 citing articles:

The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 23
A covalent compound selectively inhibits RNA demethylase ALKBH5 rather than FTO
Gan-qiang Lai, Yali Li, Heping Zhu, et al.
RSC Chemical Biology (2024) Vol. 5, Iss. 4, pp. 335-343
Open Access | Times Cited: 14
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy
Lu Liu, Yuanlai Qiu, Yuying Suo, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5382-5392
Open Access | Times Cited: 5
Discovery of Novel RNA Demethylase FTO Inhibitors Featuring an Acylhydrazone Scaffold with Potent Antileukemia Activity
Xuewu Liang, Yue Huang, Hairu Ren, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications
Penghui Li, Xiangjie Fang, Di Huang
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
FTO inhibition mitigates high-fat diet-induced metabolic disturbances and cognitive decline in SAMP8 mice
Alba Irisarri, Ana Corral, Núria Perez-Salvador, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Development of 3-Arylaminothiophenic-2-carboxylic Acid Derivatives as New FTO Inhibitors Showing Potent Antileukemia Activities
Deyan Zhang, Lu Liu, Ming Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117444-117444
Closed Access
Advancements in chemically inducible modified tRNA sequencing techniques: Elucidating novel insights into tRNA epitranscriptomics
X. Li, Linjing Mu, Jiaying Liu, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 122, pp. 118138-118138
Closed Access
m6A Demethylase FTO Drives Pancreatic Ductal Adenocarcinoma Metastasis Through Remodeling PFKM Mediated Glycolysis
Zhen Tan, Jianhui Yang, Yueyue Chen, et al.
(2025)
Closed Access
A patenting perspective of fat mass and obesity associated protein (FTO) inhibitors: 2017-present
Ze Dong, Yue Huang, Wenyang Xia, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
FTO elicits tumor neovascularization in cancer-associated fibroblasts through eliminating m6A modifications of multiple pro-angiogenic factors
Qili Liao, Hanhan Shi, Jie Yang, et al.
Cancer Letters (2024) Vol. 592, pp. 216911-216911
Closed Access | Times Cited: 4
Structure‐Activity Relationships of 2‐(Arylthio)benzoic Acid FTO Inhibitors
Chao Guo Yan, Qian Zhang, Pan Xiao, et al.
Israel Journal of Chemistry (2024) Vol. 64, Iss. 3-4
Closed Access | Times Cited: 3
N6-methyladenosine (m6A) modification in hepatocellular carcinoma
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116365-116365
Open Access | Times Cited: 3
Atomic Mutagenesis of N6-Methyladenosine Reveals Distinct Recognition Modes by Human m6A Reader and Eraser Proteins
Florian Seitz, Tina Jungnickel, Nicole Kleiber, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 11, pp. 7803-7810
Open Access | Times Cited: 3
Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future
J. J. Li, Xiaodong Wang, Honghua Zhang, et al.
Medicinal Research Reviews (2024) Vol. 45, Iss. 1, pp. 164-213
Closed Access | Times Cited: 2
M6A RNA methylation in biliary tract cancer: the function roles and potential therapeutic implications
Xuesong Bai, Jianhao Huang, Yiqun Jin, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The physiological and pathological roles of RNA modifications in T cells
Yu Deng, Jing Zhou, Huabing Li
Cell chemical biology (2024) Vol. 31, Iss. 9, pp. 1578-1592
Closed Access | Times Cited: 1
Therapeutic strategies to target the epitranscriptomic machinery
Denise Sighel, Eliana Destefanis, Alessandro Quattrone
Current Opinion in Genetics & Development (2024) Vol. 87, pp. 102230-102230
Open Access | Times Cited: 1
The Roles of RNA N6-methyladenosine Modifications in Systemic Lupus Erythematosus
Xin Xia, Rui Qu
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3223-3234
Closed Access | Times Cited: 1
Role of N6‐methyladenosine RNA modification in cancer
Yi Qu, Nannan Gao, Shengwei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 1
Discovery of the Salicylaldehyde-Based Compound DDO-02267 as a Lysine-Targeting Covalent Inhibitor of ALKBH5
W.D. Fei, Yingzhe Wang, Qi Feng, et al.
European Journal of Medicinal Chemistry (2024), pp. 117183-117183
Closed Access | Times Cited: 1
MiR-150-5p inhibits cell proliferation and metastasis by targeting FTO in osteosarcoma
LICHEN XU, Pan Zhang, Guiqi Zhang, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024), pp. 1-10
Open Access
Discovery of Photoexcited 2‐Chloro‐3,5‐Dinitrobenzoic Acid as a Chemical Deprenylase of i6A RNA
Xin Sun, Tian‐He Hui, Li Liu, et al.
ChemBioChem (2024) Vol. 25, Iss. 14
Closed Access
The m6A regulators in prostate cancer: molecular basis and clinical perspective
Yu Cao, Man Jia, Chunyan Duan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1

Scroll to top